2022 Endothelial Cell Phenotypes GRC and GRS
2022 内皮细胞表型 GRC 和 GRS
基本信息
- 批准号:10464521
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAffectAgingAreaBasic ScienceBiologicalBiologyBiomedical EngineeringBiotechnologyBloodBlood VesselsCellsCellular biologyCollaborationsCommunicationDataDevelopmentDisciplineDiseaseDisease ProgressionEndothelial CellsEnvironmentExposure toExtracellular MatrixFemaleFosteringFundingFutureGenomic approachGeographyGoalsGovernmentHealthHeterogeneityHomeostasisHumanImageIndustryInstitutionInternationalJointsKnowledgeLymphaticMinorityModelingMolecularMolecular BiologyNamesNatural regenerationOrganParticipantPathologyPeer GroupPhenotypePhysiologyPostdoctoral FellowRegenerative MedicineRegulationResearchResearch PersonnelScientistSenior ScientistSignal PathwaySignal TransductionSiteSpainSpecific qualifier valueStructureStudentsTechnologyTherapeuticTimeTissue EngineeringTissuesTranslationsUnited States National Institutes of HealthVascular DiseasesVascular Endothelial CellVascular regenerationVascularizationWorkbasebioimagingcareerclinical practicedemographicsdesignexperiencefaculty mentorinnovationinterdisciplinary collaborationlymphatic vesselmechanical forcemechanical stimulusmeetingsnovelpre-doctoralregeneration potentialregenerativerepairedresponsesocialsoundstem cellssymposiumtissue regenerationtissue repairtoolwillingness
项目摘要
Project Summary
This Gordon Research Conference (GRC), “Endothelial Cell Phenotypes in Health and Disease”, and the
accompanying Gordon Research Seminar (GRS, organized by and for trainees) of the same name have the
underlying hypothesis that a better understanding of differential endothelial cell phenotypes and functions is
distinct tissue environments is important basic knowledge, and this knowledge is crucial for proper vascular
repair and tissue regeneration. The goals are to bridge existing knowledge and communication gaps between
researchers at all levels (students, postdocs, junior and senior scientists in academia and industry) who study
endothelial cell biology and heterogeneity, and those who study vascular disease, bioimaging, and tissue
engineering and regenerative medicine. These fields have recently developed paradigms, tools and models to
aid this goal, and this integration is predicted to move all fields forward towards timely translation of basic
discoveries. This GRC will strongly foster lasting interdisciplinary interactions and collaborations amongst NIH-
funded and international vascular and stem cell biologists, between academic and industry scientists, and
develop the next cadre of scientists at the intersection of these fields by exposure to new ideas, issues and
opportunities. The associated GRS will also support these goals with an emphasis on trainee development.
The GRC Chair and vice-Chair are leaders in the field and well-suited to organize the meeting. The meeting
goals will be accomplished by bringing together a selected group of researchers (about 150 participants) to a
small, semi-isolated site (near Barcelona, Spain) for a week, in a venue and meeting structure designed to
foster extensive discussion after presentation of largely unpublished data, and to promote informal interactions
and networking through shared meals and afternoon social activities that especially benefit trainees. Invited
speakers are chosen based on excellence in research, topic, and willingness to engage trainees. Participants
will be chosen based on topic and demographics. Female and minority speakers have been invited, and those
groups will be encouraged to apply as participants. A GRS pre-meeting will be organized by trainees and for
trainees (with limited input from GRC chairs and faculty mentors that will attend the GRS), and feature
presentation of trainee work, to facilitate networking among this group and provide them with a peer group as
they transition into the larger meeting. This GRC/GRS meeting will have a strong and lasting impact on the
field, as it addresses important basic questions and health issues in vascular biology at a propitious time.
项目摘要
戈登研究会议(GRC),“健康和疾病中的内皮细胞表型”,以及
伴随着戈登研究研讨会(GRS,组织和学员)的同名有
更好地理解不同内皮细胞表型和功能的基本假设是
不同的组织环境是重要的基础知识,并且这种知识对于适当的血管生成是至关重要的。
修复和组织再生。目标是弥合现有的知识和沟通差距,
各级研究人员(学生,博士后,学术界和工业界的初级和高级科学家),
内皮细胞生物学和异质性,以及那些研究血管疾病,生物成像和组织
工程学和再生医学这些领域最近开发了范式、工具和模型,
这有助于实现这一目标,预计这种整合将推动所有领域朝着及时翻译基本
发现。该GRC将大力促进NIH之间持久的跨学科互动和合作,
资助和国际血管和干细胞生物学家,学术和工业科学家之间,
通过接触新的想法,问题和知识,在这些领域的交叉点上培养下一批科学家,
机会相关的GRS也将支持这些目标,重点是培训生的发展。
小组委员会主席和副主席是该领域的领导者,非常适合组织会议。会议
目标将通过将一组选定的研究人员(约150名参与者)聚集在一起,
一个小的,半孤立的网站(靠近西班牙巴塞罗那)一个星期,在一个场地和会议结构,旨在
在提交大部分未公布的数据后,促进广泛讨论,并促进非正式互动
通过共享膳食和下午的社交活动建立网络,这对学员特别有益。邀请
演讲者是根据研究,主题和参与培训的意愿来选择的。参与者
将根据主题和人口统计数据进行选择。邀请了女性和少数民族发言人,
欢迎团体报名参加。学员将组织一次GRS会前会议,
学员(来自将参加GRS的GRC主席和教师导师的有限输入),并具有
介绍受训者的工作,以促进这一群体之间的网络联系,并为他们提供一个同龄群体,
他们会转入更大的会议本次GRC/GRS会议将对
领域,因为它解决了重要的基础问题和健康问题,在血管生物学在一个有利的时间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen Kemper Hirschi其他文献
Karen Kemper Hirschi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen Kemper Hirschi', 18)}}的其他基金
miR-223 regulates endothelial to hematopoietic transition
miR-223 调节内皮细胞向造血细胞的转变
- 批准号:
10763971 - 财政年份:2020
- 资助金额:
$ 0.5万 - 项目类别:
miR-223 regulates endothelial to hematopoietic transition
miR-223 调节内皮细胞向造血细胞的转变
- 批准号:
10557218 - 财政年份:2020
- 资助金额:
$ 0.5万 - 项目类别:
miR-223 regulates endothelial to hematopoietic transition
miR-223 调节内皮细胞向造血细胞的转变
- 批准号:
10348182 - 财政年份:2020
- 资助金额:
$ 0.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant